ticlopidine has been researched along with Connective Tissue Diseases in 2 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
Connective Tissue Diseases: A heterogeneous group of disorders, some hereditary, others acquired, characterized by abnormal structure or function of one or more of the elements of connective tissue, i.e., collagen, elastin, or the mucopolysaccharides.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We evaluated the plasma concentrations of platelet activation markers and platelet-derived microparticles (PMP) in patients with connective tissue diseases complaining of peripheral circulation disorders (n = 16) and studied the effect of ticlopidine hydrochloride (ticlopidine) on PMP generation." | 7.70 | Effect of ticlopidine on platelet-derived microparticles in patients with connective tissue diseases. ( Fukuhara, S; Kagawa, H; Nagahama, M; Nomura, S; Ozaki, Y, 1999) |
| "We evaluated the plasma concentrations of platelet activation markers and platelet-derived microparticles (PMP) in patients with connective tissue diseases complaining of peripheral circulation disorders (n = 16) and studied the effect of ticlopidine hydrochloride (ticlopidine) on PMP generation." | 3.70 | Effect of ticlopidine on platelet-derived microparticles in patients with connective tissue diseases. ( Fukuhara, S; Kagawa, H; Nagahama, M; Nomura, S; Ozaki, Y, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Otoshi, T | 1 |
| Kataoka, Y | 1 |
| Nakagawa, A | 1 |
| Otsuka, K | 1 |
| Tomii, K | 1 |
| Kagawa, H | 1 |
| Nomura, S | 1 |
| Nagahama, M | 1 |
| Ozaki, Y | 1 |
| Fukuhara, S | 1 |
2 other studies available for ticlopidine and Connective Tissue Diseases
| Article | Year |
|---|---|
Clinical Features and Outcomes of Diffuse Alveolar Hemorrhage During Antithrombotic Therapy: A Retrospective Cohort Study.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Cilostazol; Clopidogrel; Connective Tissue Diseases; Female | 2016 |
Effect of ticlopidine on platelet-derived microparticles in patients with connective tissue diseases.
Topics: Antigens, CD; Biomarkers; Blood Platelets; Connective Tissue Diseases; Endothelium, Vascular; Female | 1999 |